Earlier this month, health officials in Qatar reported three laboratory-confirmed cases of Middle East respiratory syndrome (MERS-CoV) infection.
Researchers conducted a review of molecular and serological investigations through PubMed and EMBASE from September 2012 to 15 November 2018 to measure sub-clinical or asymptomatic Middle East Respiratory syndrome coronavirus (MERS-CoV) infection within and outside of health care settings.
The United Arab Emirates (UAE) has a confirmed case of Middle East respiratory syndrome (MERS) in a 44-year-old male non-national farmer from Al Ain city.
The global health security community should emphasize the danger of zoonotic disease outbreaks and how those diseases can cross the animal-human species barrier by using Middle East respiratory syndrome coronavirus (MERS-CoV) as an example.
The World Health Organization (WHO) reported 14 Middle East respiratory syndrome (MERS) cases in May.
Dromedary camels play a significant part in the circulation and the zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Researchers demonstrated that Bactrian camels are also susceptible to MERS-CoV infection and shed large quantities of infectious virus in nasal secretions.
The study found the research, case fatality rate was 30.5 percent for males and 25.8 percent for females.
The study investigated risk factors for Middle East respiratory syndrome (MERS) seropositivity in animal market and slaughterhouse workers at a site previously associated with zoonotic transmission of MERS. Given the large number of camels present, including many young camels, and the mixing of camels from multiple sources, this site probably facilitates MERS transmission among camels. Results demonstrated a relatively high MERS seroprevalence in workers at this site, ranging from six percent to 19 percent at each round across all occupations.
Researchers made two versions of a potential vaccine and evaluated their effectiveness and safety in mice that were genetically altered to have more human-like immune responses. After the mice were vaccinated and then infected with Middle East respiratory syndrome (MERS), both vaccines protected the mice against clinical signs of disease and death.
The Saudi Ministry of Health is reporting two more Middle East respiratory syndrome (MERS) cases from Al Khafji , both of which are currently listed as `under investigation'. As with the previous four cases, all are older males.